The WHO recommends a vaccination scheme against influenza A at a dose to the whole population
Sunday, November 1st, 2009The World Health Organization (WHO) recommended Friday (October 30) during a press conference call a scheme vaccine against influenza A (H1N1) at a dose with products certified for all subjects aged over of 6 months.
She also called for the administration of any type of licensed vaccine against influenza A (H1N1), adjuvanted or not, pregnant women, as well as the general possibility of co-administer the vaccine against influenza A ( H1N1) simultaneously with that against seasonal influenza.
These recommendations are based on those issued by the Strategic Advisory Group of Experts on immunization (SAGE), an independent expert committee on immunization with the WHO, which met on Wednesdays only the issue of vaccination against Influenza A (H1N1) and has updated its recommendations issued in July, said Dr. Marie-Paule Kieny, Director of the Initiative for Vaccine Research at WHO.
On the issue of immunization schedule, the specialist said that experts had examined the clinical trials, as well as the decisions and recommendations of the national authorities.
They decided to recommend a dose for all subjects older than 6 months, with the live attenuated vaccine, inactivated, adjuvant or not, and especially those of GlaxoSmithKline (Pandemrix *) and Novartis (Focetria *) on the database “of immune response and public health considerations,” she said. (more…)